FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

29,056 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 6600 - 6800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113883.3.526.2.1571Hypotony of Eyeactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1572Hypotony of Eyeactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1574Injury to Optic Nerve and Pathwaysactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1575Injury to Optic Nerve and Pathwaysactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1577Central Corneal Ulceractive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1578Central Corneal Ulceractive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1582Open Wound of Eyeballactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1583Open Wound of Eyeballactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1587Pathologic Myopiaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1588Pathologic Myopiaactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1590Posterior Lenticonusactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1591Posterior Lenticonusactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1601Retrolental Fibroplasiasactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1603Retrolental Fibroplasiasactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1612Traumatic Cataractactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1613Traumatic Cataractactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1615Uveitisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1617Uveitisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1618Vascular Disorders of Iris and Ciliary Bodyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1620Vascular Disorders of Iris and Ciliary Bodyactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1621Visual Field Defectsactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1623Visual Field Defectsactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1626Amblyopiaactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1628Amblyopiaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1632Choroidal Degenerationsactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1634Choroidal Degenerationsactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1635Choroidal Detachmentactive2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1637Choroidal Detachmentactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1638Choroidal Hemorrhage and Ruptureactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1640Choroidal Hemorrhage and Ruptureactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1641Degeneration of Macula and Posterior Poleactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1643Degeneration of Macula and Posterior Poleactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1644Degenerative Disorders of Globeactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1646Degenerative Disorders of Globeactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1647Diabetic Macular Edemaactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1649Diabetic Macular Edemaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1653Disorders of Optic Chiasmactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1655Disorders of Optic Chiasmactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1656Disorders of Visual Cortexactive2021-04ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1658Disorders of Visual Cortexactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1659Disseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1661Disseminated Chorioretinitis and Disseminated Retinochoroiditisactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1662Focal Chorioretinitis and Focal Retinochoroiditisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1664Focal Chorioretinitis and Focal Retinochoroiditisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1665Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1667Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromesactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1668Hereditary Choroidal Dystrophiesactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1670Hereditary Choroidal Dystrophiesactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1671Hereditary Retinal Dystrophiesactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1673Hereditary Retinal Dystrophiesactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1677Nystagmus and Other Irregular Eye Movementsactive2021-03ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1679Nystagmus and Other Irregular Eye Movementsactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1680Optic Atrophyactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1682Optic Atrophyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1683Optic Neuritisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1685Optic Neuritisactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1686Other and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1688Other and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1689Other Background Retinopathy and Retinal Vascular Changesactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1691Other Background Retinopathy and Retinal Vascular Changesactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1695Other Disorders of Optic Nerveactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1697Other Disorders of Optic Nerveactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1701Other Endophthalmitisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1703Other Endophthalmitisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1707Prior Penetrating Keratoplastyactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1709Prior Penetrating Keratoplastyactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1713Purulent Endophthalmitisactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1715Purulent Endophthalmitisactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1716Retinal Detachment with Retinal Defectactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1718Retinal Detachment with Retinal Defectactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1719Retinal Vascular Occlusionactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1721Retinal Vascular Occlusionactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1722Other Proliferative Retinopathyactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1724Other Proliferative Retinopathyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1728Separation of Retinal Layersactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1730Separation of Retinal Layersactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1731Visual Acuity 20/40 or Betteractive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.175Hypotensionactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1752Speech and Hearing Evaluationactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.176Arrhythmiaactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1766Morgagnian Cataractactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1767Morgagnian Cataractactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1769Macular Scar of Posterior Polaractive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.177Atrioventricular Blockactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1770Macular Scar of Posterior Polaractive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1771Ophthalmological Servicesactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1772Annual Wellness Visitactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1773Speech and Hearing Evaluationactive2019-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1774Occupational Therapy Evaluationactive2021-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1775Behavioral Neuropsych Assessmentactive2019-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1776Psych Visit Diagnostic Evaluationactive2020-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1777Psych Visit Psychotherapyactive2019-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1778Psychoanalysisactive2019-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1779Group Psychotherapyactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.178Cardiac Pacer in Situactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1780Psych Visit for Family Psychotherapyactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1781Best Corrected Visual Acuity Exam Using Snellen Chartactive2021-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.526.2.180Hypotensionactive2023-03ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.181Arrhythmiaactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.183Cardiac Pacer in Situactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.185Hypotensionactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.186Arrhythmiaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.187Atrioventricular Blockactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1912Major Depressive Disorder Activeactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.1918Major Depressive Disorder Activeactive2023-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.1923Psych Visit Diagnostic Evaluationactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.1924Cardiac Pacer in Situactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.408Bradycardiaactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.410Bradycardiaactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.411Bradycardiaactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.422Tobacco Useractive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.423Tobacco Use Cessation Pharmacotherapyactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.526.2.424Tobacco Use Cessation Counselingactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.425Tobacco Use Cessation Counselingactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.450Pain Warranting Further Investigation for Prostate Canceractive2023-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.469Bilateral Oophorectomyactive2017-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.470Bilateral Oophorectomyactive2024-01ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.483Chemotherapyactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.484Chemotherapyactive2021-08ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.526.2.511Tobacco Non Useractive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.532Pregnancyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.56Coronary Artery Disease No MIactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.57Coronary Artery Disease No MIactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.58Initial Myocardial Infarctionactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.589End Stage Renal Diseaseactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.59Asthmaactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.590End Stage Renal Diseaseactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.60Asthmaactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.61Asthmaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.73Primary Open Angle Glaucomaactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.74Primary Open Angle Glaucomaactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.76Diabetic Retinopathyactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.80Diabetic Retinopathyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.859Left Ventricular Systolic Dysfunctionactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.860Moderate or Severeactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.861Moderate or Severe LVSDactive2017-05ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.2.91Prostate Canceractive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.526.2.92Prostate Canceractive2025-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.526.3.1002Chronic Kidney Disease, Stage 5active2020-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1005Dementia and Mental Degenerationsactive2020-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1006Standardized Tools Score for Assessment of Cognitionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1007Medical Reasonactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1008Patient Reasonactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1010Canceractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1011Occupational Therapy Evaluationactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1012Patient Provider Interactionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1018Psych Visit for Family Psychotherapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1023Behavioral or Neuropsych Assessmentactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1026Radiation Treatment Managementactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1027Chemotherapy Administrationactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1028Standardized Pain Assessment Toolactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1090Moderate or Severe LVSDactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1091Left Ventricular Systolic Dysfunctionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1092Moderate or Severeactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1134Ejection Fractionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1139ACE Inhibitor or ARB or ARNIactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1140Patient Reason for ACE Inhibitor or ARB Declineactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1141Psychoanalysisactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1151Renal Failure Due to ACE Inhibitoractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1170Tobacco Useractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1174Beta Blocker Therapyactive2021-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1176Heart Rateactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1177Allergy to Beta Blocker Therapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1178Intolerance to Beta Blocker Therapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1184Beta Blocker Therapy for LVSDactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1187Group Psychotherapyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1189Tobacco Non Useractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1190Tobacco Use Cessation Pharmacotherapyactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1193Cardiac Paceractive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1211Allergy to ACE Inhibitor or ARBactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1212Intolerance to ACE Inhibitor or ARBactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1240Annual Wellness Visitactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1241Acute and Subacute Iridocyclitisactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1251Macular Examactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1259Limited Life Expectancyactive2025-04ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1278Tobacco Use Screeningactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1283Level of Severity of Retinopathy Findingsactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1285Ophthalmological Servicesactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1320Macular Edema Findings Presentactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1332Cognitive Assessmentactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1333Cup to Disc Ratioactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1334Optic Disc Exam for Structural Abnormalitiesactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1409Burn Confined to Eye and Adnexaactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1410Cataract Secondary to Ocular Disordersactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1411Cataract Surgeryactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1412Cataract Congenitalactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1413Cataract Mature or Hypermatureactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1414Cataract Posterior Polaractive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1415Certain Types of Iridocyclitisactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1416Chronic Iridocyclitisactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1417Cloudy Corneaactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1418Corneal Edemaactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1419Disorders of Cornea Including Corneal Opacityactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1423Glaucomaactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1424Hereditary Corneal Dystrophiesactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1426Hypotony of Eyeactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1427Injury to Optic Nerve and Pathwaysactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1428Central Corneal Ulceractive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1430Open Wound of Eyeballactive2021-04ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.526.3.1432Pathologic Myopiaactive2022-03ushl7vsac